180 related articles for article (PubMed ID: 6352025)
1. Role of platelet-active drugs in coronary artery disease.
Sherry S
Cardiovasc Clin; 1983; 14(1):173-89. PubMed ID: 6352025
[No Abstract] [Full Text] [Related]
2. A critical appraisal of the clinical efficiency of anti-platelet drugs.
Lecompte T; Samama M
Agents Actions Suppl; 1986; 20():203-14. PubMed ID: 3544741
[No Abstract] [Full Text] [Related]
3. Platelet-inhibitory therapy in reconstructive arterial surgery.
McCollum CN; Goldman M
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():301-9. PubMed ID: 3159216
[No Abstract] [Full Text] [Related]
4. Clinical trials in thrombosis: secondary prevention of myocardial infarction.
Klimt CR; Doub PH; Doub NH
Thromb Haemost; 1976 Feb; 35(1):49-56. PubMed ID: 785688
[TBL] [Abstract][Full Text] [Related]
5. Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery.
Cairns JA
Cardiovasc Clin; 1987; 18(1):231-46. PubMed ID: 3300983
[No Abstract] [Full Text] [Related]
6. [Clinical application and evaluation of anti-platelet agents].
Yasunaga K
Nihon Rinsho; 1978 Dec; 36(12):3884-94. PubMed ID: 372628
[No Abstract] [Full Text] [Related]
7. Platelet inhibitors in the treatment of thrombosis.
Hirsh J
Clin Invest Med; 1978; 1(3-4):191-206. PubMed ID: 391458
[No Abstract] [Full Text] [Related]
8. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Genton E; Gent M; Hirsh J; Harker LA
N Engl J Med; 1975 Dec; 293(23):1174-8. PubMed ID: 1102977
[No Abstract] [Full Text] [Related]
9. Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Harker LA; Hirsh J; Gent M; Genton E
Prog Hematol; 1975; 9():229-54. PubMed ID: 766074
[No Abstract] [Full Text] [Related]
10. Secondary prevention of coronary events after myocardial infarction. Beta-blockers and/or anti-platelets: to whom, when and for how long. A review.
Bélanger GL; Lavallée JP; Lenis J; Ouellet CA
Can J Cardiol; 1985 Mar; 1(2):97-105. PubMed ID: 2864991
[TBL] [Abstract][Full Text] [Related]
11. Platelet function inhibitors: their clinical use.
Fuster V; Didisheim P
Adv Intern Med; 1978; 23():251-64. PubMed ID: 343540
[No Abstract] [Full Text] [Related]
12. [Prophylactic value of platelet anti-aggregants in coronary disease].
Verstraete M
Clin Ter; 1979 Oct; 91(2):117-27. PubMed ID: 396098
[No Abstract] [Full Text] [Related]
13. [Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
Shalaev SV
Kardiologiia; 1989 Sep; 29(9):116-20. PubMed ID: 2687554
[No Abstract] [Full Text] [Related]
14. Platelets and antiplatelet therapy in ischemic heart disease.
Frishman WH; Miller KP
Curr Probl Cardiol; 1986 Feb; 11(2):69-136. PubMed ID: 2936576
[No Abstract] [Full Text] [Related]
15. Trials of antiplatelet drugs: some methodological considerations.
Armitage P
Rev Epidemiol Sante Publique; 1979 Sep; 27(2):87-90. PubMed ID: 538303
[No Abstract] [Full Text] [Related]
16. The current status of platelet suppressive drugs in the treatment of thrombosis.
Hirsh J; Gent M; Genton E
Thromb Diath Haemorrh; 1975 Jun; 33(3):406-16. PubMed ID: 1098213
[No Abstract] [Full Text] [Related]
17. Platelets and prostaglandins in sudden death: therapeutic implications.
Gelman JS; Mehta J
Cardiovasc Clin; 1985; 15(3):65-80. PubMed ID: 2870807
[No Abstract] [Full Text] [Related]
18. Antiplatelet drugs in thromboembolism.
Hirsh J
Postgrad Med; 1979 Sep; 66(3):119-23, 126-7. PubMed ID: 382146
[TBL] [Abstract][Full Text] [Related]
19. Status of antiplatelet drugs in coronary heart disease.
Mehta J; Mehta P
JAMA; 1979 Jun; 241(24):2649-51. PubMed ID: 439365
[No Abstract] [Full Text] [Related]
20. Antithrombotic agents in coronary artery disease.
Resnekov L; Chediak J; Hirsh J; Lewis D
Chest; 1986 Feb; 89(2 Suppl):54S-67S. PubMed ID: 3510831
[No Abstract] [Full Text] [Related]
[Next] [New Search]